Testing challenges: evaluation of novel diagnostics and molecular biomarkers.
Through the lens of public health genomics, this article probes certain issues that concern the evaluation of diagnostic tests and molecular biomarkers, and the accompanying policy and regulatory implications. It begins with some conceptual remarks followed by a discussion of evaluation, translation, and regulation, and their importance for public health.
Zimmern
Ronald L
RL
PHG Foundation, Cambridge. ron.zimmern@phgfoundation.org
D015415:Biomarkers; D003256:Community Participation; D003955:Diagnostic Tests, Routine; D004059:Diffusion of Innovation; D033161:Government Regulation; D006293:Health Promotion; D011315:Preventive Medicine; D011634:Public Health; D006113:United Kingdom
D015415:Biomarkers